Establishment Labs (NASDAQ:ESTA) Receives “Overweight” Rating from Stephens

Stephens reiterated their overweight rating on shares of Establishment Labs (NASDAQ:ESTA) in a research note published on Thursday,Benzinga reports. They currently have a $52.00 price target on the stock.

Establishment Labs Stock Performance

NASDAQ:ESTA opened at $42.87 on Thursday. Establishment Labs has a 52-week low of $28.16 and a 52-week high of $60.12. The business’s fifty day moving average is $37.50 and its 200 day moving average is $41.35. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of -16.62 and a beta of 1.12.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The business had revenue of $44.51 million for the quarter, compared to analysts’ expectations of $44.45 million. Research analysts predict that Establishment Labs will post -2.41 EPS for the current year.

Hedge Funds Weigh In On Establishment Labs

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ESTA. Toronto Dominion Bank purchased a new position in Establishment Labs during the fourth quarter worth about $24,879,000. Brown Advisory Inc. grew its position in Establishment Labs by 23.1% during the fourth quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company’s stock worth $107,729,000 after buying an additional 438,057 shares in the last quarter. Capital Research Global Investors boosted its holdings in shares of Establishment Labs by 29.3% in the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company’s stock worth $88,064,000 after purchasing an additional 433,484 shares in the last quarter. Voya Investment Management LLC boosted its holdings in shares of Establishment Labs by 7,249.5% in the 4th quarter. Voya Investment Management LLC now owns 408,262 shares of the company’s stock worth $18,809,000 after purchasing an additional 402,707 shares in the last quarter. Finally, Millennium Management LLC boosted its holdings in shares of Establishment Labs by 96.9% in the 4th quarter. Millennium Management LLC now owns 711,691 shares of the company’s stock worth $32,788,000 after purchasing an additional 350,213 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.